Myocardial stunning refers to a state of prolonged contractile dysfunction of post-ischemic myocardium in which normal myocardial function is gradually restored after a given recovery period. The first description of this phenomenon dates back to the early 30's, where Tennant and Wiggers demonstrated in their seminal experiments in open-chest dogs that, within 60 seconds of coronary occlusion, myocardial contractions in the ischemic zone change from active systolic shortening to passive systolic lengthening.
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Myocardial stunning refers to a state of prolonged contractile dysfunction of post-ischemic myocardium in which normal myocardial function is gradually restored after a given recovery period. The first description of this phenomenon dates back to the early 30's, where Tennant and Wiggers demonstrated in their seminal experiments in open-chest dogs that, within 60 seconds of coronary occlusion, myocardial contractions in the ischemic zone change from active systolic shortening to passive systolic lengthening. 1 Forty years later, Heyndrickx and colleagues revealed that while regional electrograms normalize within seconds and coronary flow is restored within minutes, contractile dysfunction lasts for up to 2 hours after a 5-minutes occlusion and for up to 24 hours after a 15-minutes occlusion. 2 Two important concepts were born: Post-ischemic stunning is determined by (i) the severity and (ii) the duration of myocardial ischemia. This phenomenon is explained by changes induced in contractile proteins and in the cellular ionic environment by a brief coronary occlusion which may outlast normalization of blood flow by several hours. In fact, after experimental coronary occlusion, myocardial ATP concentration declines quickly and metabolites of ATP such as adenosine, hypoxanthine, and inosine accumulate. Since the myocardium is permeable to these substances, they are washed out from the ischemic myocardium during reperfusion. As a consequence, the re-synthesis of ATP is delayed and the period of reduced ATP concentration is prolonged. 3, 4 The first unequivocal direct evidence for myocardial stunning in humans was published by Gerber and colleagues in 1999. 5 They investigated 14 patients with unstable angina who were successfully revascularized, but showed persistent wall motion abnormalities 48 hours after revascularization despite restoration of myocardial blood flow (MBF). Four months later, 86% of patients displayed spontaneous improvement in segmental wall motion. In patients with stable angina, Barnes and colleagues observed that dobutamine stress induced similar reductions of myocardial contractility in ischemic myocardium, which recovered slowly over the course of several hours. 6 Interestingly, if dobutamine stress was repeated within 1 hour, myocardial stunning appeared more severe and persisted for a longer period. 7 Thus, a third concept was established: repetitive ischemic episodes lead to cumulative myocardial stunning.
Hence, the presence of myocardial stunning has been recognized as a marker of more severe or extensive coronary artery disease (CAD) in radionuclide myocardial perfusion studies (MPS) and other diagnostic imaging tests. [8] [9] [10] Its prognostic value has been established by several trials, although in some studies its independent predictive value was nullified when correcting for clinical characteristics and perfusion variables. 11, 12 Interestingly, transient post-ischemic stunning is a stronger predictor of coronary ischemic events while reduced resting ejection fraction (EF) is rather associated with cardiac death and hospitalization for heart failure. 13 Post-ischemic stunning can be quantified on radionuclide SPECT studies from regional wall motion abnormalities or more globally as a reduction in left ventricular EF or increase in end-systolic volumes post-stress. This requires comparison of gated stress and rest SPECT datasets posing significant challenges to MPS protocols. For instance, post-stress EF decrease is related to the time elapsed between stress testing and image acquisition: early image acquisition (10-15 minutes post-stress) may detect greater reductions in post-stress EF than delayed imaging (45-60 minutes). [14] [15] [16] [17] Moreover, if the delay between stress and rest imaging is too short to allow for recovery of myocardial contractility, the severity of post-stress EF decrease may be underestimated or appear as fixed myocardial dysfunction. This may affect detection of post-ischemic stunning in 1-day protocols with stressfirst imaging which are intended to improve logistics and patient comfort by short inter-scan delays.
In the current issue of the Journal of Nuclear Cardiology, Marcassa et al. 18 investigate these open questions with an innovative retrospective multicenter study. The authors included 1121 patients from six institutions in Italy undergoing ECG-gated stress/rest MPS with either a 1-day (n = 676) or a 2-day protocol (n = 445) in which coronary angiography was available. From this patient population, 490 propensity-matched patients undergoing either a 1-day (n = 245) or 2-day (n = 245) protocol were selected, and left ventricular volumes and EF were compared for both, stress and rest gated cardiac SPECT. Patients in the 1-day group were scanned with 99m Tc-tetrofosmin while 99m Tc-sestamibi was used for the 2-day protocol. Moreover, clinical follow-up was obtained for an average of 3.2 years and the predictive value of perfusion and non-perfusion SPECT variables tested in multivariate regression models. Both groups were well balanced with regard to baseline characteristics, CAD extent on invasive angiography and severity and extent of ischemia. There were no significant differences in post-stress and rest EF between the two groups. However, in patients with severe ischemia (SDS [8) post-stress EF decrease (DEF) was significantly higher in the 2-day protocol (DEF = -7.5%) compared to the 1-day protocol (DEF = -2.2%) indicating underestimation of post-ischemic stunning in the former group. This notion is further underlined by the lack of DEF to predict cardiovascular events on multivariate regression analysis, while poststress EF, age, gender extent of ischemia, CAD extent, and end-systolic volume emerged as independent predictors of clinical outcome.
The authors should be congratulated for this elaborate multicenter study highlighting an important aspect of cardiac SPECT that occasionally sinks into oblivion. It raises important issues of potential underestimation of post-stress DEF with current 1-day MPS protocols. It is crucial to understand the timing of scans used in the present study for appropriate interpretation: the average inter-scan delay was 164 minutes for the 1-day protocol and approximately 24 hours in the 2-day group. As previously mentioned, recovery of myocardial stunning depends on the severity of ischemia and may range from 120 minutes 6 to 6 hours or longer 2 in stable patients, hence an inter-scan delay of 164 minutes may have been too short to pick-up full recovery of contractility with the 1-day protocol. The 2-day protocol, on the other hand, offers the possibility to assess the full extent of myocardial stunning. Furthermore, the ''stress-to-camera'' delay was on average 16 minutes for the 1-day protocol versus 38 minutes in the 2-day group. Even though the majority of the patients in the 1-day group underwent physical exercise stress (for which generally hepatobiliary uptake is less than with vasodilators or at rest), the average 16 minutes delay is considerably lower than the recommended 30-60 minutes. 19 However, despite the potentially higher subdiaphragmatic activity of 99m Tc-tracers (compared to 201 Thallium), studies suggest that early image acquisition is feasible and as accurate as delayed imaging (21). Moreover, tetrofosmin has a more favorable biodistribution than sestamibi, and its rapid accumulation in the myocardium and the relatively fast liver kinetic favor early image acquisition. Nevertheless, it is unlikely that the observed differences in ''stress-to-camera'' delay may have affected the results of this study, since both were considerably shorter than the expected recovery period.
As the authors state themselves, some limitations exist and should be briefly acknowledged. One of them is the retrospective design of the study which (despite propensity score matching) does not allow controlling for hidden biases. Furthermore, different tracers ( 99m Tctetrofosmin and -sestamibi) were applied. However, it is unlikely that the small differences in tracer pharmacokinetics between both compounds may have affected the results. Additionally, the authors do not report the number of bins per cardiac cycle (8 vs 16) employed for the gated SPECT analysis. A lower rate of bins per cycle may underestimate EF, and thereby affect the results of the present study. Furthermore, the clinical endpoint analysis was largely driven by revascularizations (n = 240) while cardiac death and acute coronary syndromes occurred only in 52 patients. However, it is likely that the majority of revascularization procedures were triggered by the ischemic findings on SPECT thereby not representing true clinical endpoints. This is why a 2-or 3-month ''blinding period'' after the MPS is used by many investigators to include only unplanned revascularizations as clinical endpoints. However, when revascularization was removed from multivariate regression models, the analysis was underpowered to allow for any firm conclusion.
Ways to overcome the limitations of 1-day protocols for assessment of post-ischemic stunning exist: changing the order of studies within a 1-day protocol (i.e., rest-first) avoids interference of post-ischemic stunning with resting left ventricular EF. However, stress-first protocols are generally preferred over restfirst, since they avoid shine-through artifacts from background activity obscuring perfusion defects on the stress images and allow flexibility for stress-only imaging. With the present study, Marcassa and colleagues add important information highlighting the interaction between imaging methodology and interpretability of findings. A large variety of imaging protocols exist for MPS, offering the physician the flexibility to adapt the protocol to his or her patient's particular needs. However, this requires a profound knowledge of methodologies in order be able to interpret the results in the context of each individual protocol. Ultimately, with the current evidence, every cardiac imaging lab and every nuclear physician should decide on an individual basis whether the (questionable) incremental prognostic value of post-stress DEF and slightly reduced radiation dose of the 2-day protocol outweighs the additional expenses in logistics and time on the patients' side.
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